요약정보
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: focus on antipsychotics.
- Resource Type
- Academic Journal
- Authors
- Hart XM; Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Gründer G; Central Institute of Mental Health, Department of Molecular Neuroimaging, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; German Center for Mental Health (DZPG), partner site Mannheim - Heidelberg - Ulm.; Ansermot N; Unit of Pharmacogenetics and Clinical Psychopharmacology, Center for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Prilly, Switzerland.; Conca A; Dipartimento di Psichiatria, Comprensorio Sanitario di Bolzano, Bolzano, Italy.; Corruble E; Université Paris-Saclay, AP-HP, Service Hospitalo-Universitaire de Psychiatrie, Hôpital de Bicêtre.; Equipe MOODS, Inserm U1018, CESP (Centre de Recherche en Epidémiologie et Sante des Populations), Le Kremlin-Bicêtre, France.; Crettol S; Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital and University of Lausanne, Prilly, Switzerland.; Cumming P; Department of Nuclear Medicine, Bern University Hospital, Bern, Switzerland.; School of Psychology and Counseling, Queensland University of Technology, Brisbane, Australia.; Hefner G; Vitos Clinic for Forensic Psychiatry, Forensic Psychiatry, Eltville, Germany.; Frajerman A; Université Paris-Saclay, AP-HP, Service Hospitalo-Universitaire de Psychiatrie, Hôpital de Bicêtre.; Equipe MOODS, Inserm U1018, CESP (Centre de Recherche en Epidémiologie et Sante des Populations), Le Kremlin-Bicêtre, France.; Howes O; Department of Psychosis Studies, IoPPN, King's College London, De Crespigny Park, London, SE5 8AF, UK.; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK.; Jukic M; Department of Physiology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia and Pharmacogenetics Section, Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden.; Kim E; Department of Psychiatry, Seoul National University College of Medicine, Republic of Korea.; Kim S; Department of Neuropsychiatry, Seoul National University Bundang Hospital, Republic of Korea.; Manisalco I; Dipartimento di Psichiatria, Comprensorio Sanitario di Bolzano, Bolzano, Italy.; Moriguchi S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Müller DJ; Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Würzburg, Germany.; Pharmacogenetics Research Clinic, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada, and Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Nakajima S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Osugo M; Department of Psychosis Studies, IoPPN, King's College London, De Crespigny Park, London, SE5 8AF, UK.; Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK.; Paulzen M; Department of Psychiatry, Psychotherapy and Psychosomatics, RWTH Aachen University.; JARA - Translational Brain Medicine, Aachen, Germany; Alexianer Center for Mental Health, Aachen, Germany.; Ruhe HG; Department of psychiatry, Radboudumc, Nijmegen, Netherlands; Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, Netherlands.; Scherf-Clavel M; Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Würzburg, Germany.; Schoretsanitis G; Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, 8032 Zurich, Switzerland.; Serretti A; Department of Medicine and Surgery, Kore University of Enna, Italy.; Spina E; Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.; Spigset O; Department of Clinical Pharmacology, St. Olav University Hospital, Trondheim, Norway, and Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Steimer W; Institute of Clinical Chemistry and Pathobiochemistry, Technical University Munich, Munich, Germany.; Süzen HS; Department of Pharmaceutic Toxicology, Faculty of Pharmacy, Ankara University, Ankara, Turkey.; Uchida H; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.; Unterecker S; Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Würzburg, Germany.; Vandenberghe F; Unit of Pharmacogenetics and Clinical Psychopharmacology, Centre for Psychiatric Neuroscience, Department of Psychiatry, Lausanne University Hospital, Prilly, Switzerland.; Verstuyft C; Department of Molecular Genetics, Pharmacogenetics and Hormonology Bicêtre University Hospital Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Le Kremlin Bicêtre, F-94275, France.; CESP, MOODS Team, INSERM UMR 1018, Medicine Faculty, Paris-Saclay University, Le Kremlin Bicêtre, France.; Zernig G; Department of Pharmacology, Medical University Innsbruck; Private Practice for Psychotherapy and Court-Certified Witness, Hall in Tirol, Austria.; Hiemke C; Department of Psychiatry and Psychotherapy and Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of Mainz, Germany.; Eap CB; Unit of Pharmacogenetics and Clinical Psychopharmacology, Department of Psychiatry, Centre for Psychiatric Neuroscience, Lausanne University Hospital, University of Lausanne, 1008 Prilly, Switzerland.; School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Geneva, Switzerland.; Center for Research and Innovation in Clinical Pharmaceutical Sciences, University of Lausanne, Lausanne, Switzerland.; Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, University of Lausanne, Lausanne, Switzerland.
- Source
- Publisher:
Informa Healthcare Country of Publication: England NLM ID: 101120023 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1814-1412 (Electronic) Linking ISSN:15622975 NLM ISO Abbreviation: World J Biol Psychiatry Subsets: MEDLINE - Subject
- Language
- English